ITVISMA (onasemnogene abeparvovec-brve) injection
ITVISMA is an adeno-associated virus (AAV) vector-based gene therapy indicated for the treatment of spinal muscular atrophy (SMA) in adult and pediatric patients 2 years of age and older with confirmed mutation in SMN1 gene. Under the CDSCO Named Patient Program, Indian patients can legally import breast cancer drugs that are FDA-approved in other countries but not commercially marketed in India.
| Brand Name: | ITVISMA |
| Generic Name: | onasemnogene abeparvovec-brve injection |
| Strength: | Each single-dose vial contains 1.2 × 1014 vg of onasemnogene abeparvovec in 3 mL of suspension. ITVISMA has a nominal concentration of 4 ×1013 vg/mL, and each vial contains an extractable volume of not less than 3 mL. |
| Manufacturer: | Novartis Gene Therapies |
| Approved By: | EMA, USFDA |
Source Details: Patient Information.
Get access ITVISMA for spinal muscular atrophy (SMA) Treatment through Named-Patient Import in India
IPN, New Delhi serves as a facilitator for the procurement of specialized drugs on behalf of patients or treating doctors, enabling access to ITVISMA (onasemnogene abeparvovec-brve) injection for personal use. For any queries, including information regarding the cost of the pharmaceutical product in India, please contact the IPN Healthcare Support Team via email or at the following numbers: Mobile/WhatsApp: Mr. Tarun: +91 9891 296 838 | Mr. Neeraj: +91 9811 747 774.
Contact Info
CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.
MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398
EMAIL ID:
Onasemnogene abeparvovec was developed to treat spinal muscular atrophy, a disease linked to a mutation in the survival motor neuron 1 (SMN1) gene on chromosome 5q and diagnosed predominantly in young children that causes progressive loss of muscle function and frequently death. The medication is administered as an intravenous infusion.
ITVISMA (onasemnogene abeparvovec-brve) suspension, for intrathecal injection Initial U.S. Approval: 2025
Is ITVISMA (onasemnogene abeparvovec-brve) in India?
ITVISMA (onasemnogene abeparvovec-brve) may be accessed in India through a named-patient import process with a valid doctor’s prescription, and Indian Pharma Network (IPN), New Delhi, assists with compliant sourcing and delivery of specialty medicines subject to regulatory approvals.
How to get ITVISMA injection delivered in India?
Indian Pharma Network (IPN), based in New Delhi, helps patients and healthcare providers with the sourcing and import coordination of specialty medicines in compliance with applicable Indian regulations. Availability, import eligibility, pricing, and delivery timelines may vary and are subject to regulatory approvals and documentation requirements.
IPN having representation in Delhi, Gurugram, Mumbai, Bengaluru, Kolkata, Chennai, Pune, Ahmedabad, Hyderabad, Chandigarh, Jaipur, and Lucknow.
Who can help source ITVISMA injection in India legally?
Named-patient import facilitator contact details
Company Name: Indian Pharma Network (IPN)
Address: 60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016
For sourcing and import coordination of specialty medicines, contact:
Mr. Tarun: +91 9891 296 838
Mr. Neeraj: +91 9811 747 774
Email: info@indianpharmanetwork.co.in
Patients are advised to independently verify the credentials, licensing, and regulatory compliance of any facilitator before proceeding.
Note:
We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient. Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India.
Indian Pharma Network (IPN), New Delhi. India
Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa
Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398
Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in